These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7774 related articles for article (PubMed ID: 12611083)

  • 1. Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategies.
    Kessler TA; Pfeifer A; Silletti S; Mesters RM; Berdel WE; Verma I; Cheresh D
    Ann Hematol; 2002; 81 Suppl 2():S69-70. PubMed ID: 12611083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2.
    Pfeifer A; Kessler T; Silletti S; Cheresh DA; Verma IM
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12227-32. PubMed ID: 11035804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism.
    Roca C; Primo L; Valdembri D; Cividalli A; Declerck P; Carmeliet P; Gabriele P; Bussolino F
    Cancer Res; 2003 Apr; 63(7):1500-7. PubMed ID: 12670896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model.
    Kim SK; Cargioli TG; Machluf M; Yang W; Sun Y; Al-Hashem R; Kim SU; Black PM; Carroll RS
    Clin Cancer Res; 2005 Aug; 11(16):5965-70. PubMed ID: 16115940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
    Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
    Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis.
    Lee HJ; Lee EO; Rhee YH; Ahn KS; Li GX; Jiang C; Lü J; Kim SH
    Carcinogenesis; 2006 Dec; 27(12):2455-63. PubMed ID: 16777983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth.
    Martínez A; Zudaire E; Portal-Núñez S; Guédez L; Libutti SK; Stetler-Stevenson WG; Cuttitta F
    Cancer Res; 2004 Sep; 64(18):6489-94. PubMed ID: 15374959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity.
    Brooks PC; Silletti S; von Schalscha TL; Friedlander M; Cheresh DA
    Cell; 1998 Feb; 92(3):391-400. PubMed ID: 9476898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
    Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
    Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of angiogenesis by Abeta peptides.
    Paris D; Townsend K; Quadros A; Humphrey J; Sun J; Brem S; Wotoczek-Obadia M; DelleDonne A; Patel N; Obregon DF; Crescentini R; Abdullah L; Coppola D; Rojiani AM; Crawford F; Sebti SM; Mullan M
    Angiogenesis; 2004; 7(1):75-85. PubMed ID: 15302999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of stat3 in human melanoma promotes brain metastasis.
    Xie TX; Huang FJ; Aldape KD; Kang SH; Liu M; Gershenwald JE; Xie K; Sawaya R; Huang S
    Cancer Res; 2006 Mar; 66(6):3188-96. PubMed ID: 16540670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
    Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
    Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocalcin is angiogenic in vivo.
    Cantatore FP; Crivellato E; Nico B; Ribatti D
    Cell Biol Int; 2005 Jul; 29(7):583-5. PubMed ID: 15979904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
    Olsson AK; Johansson I; Akerud H; Einarsson B; Christofferson R; Sasaki T; Timpl R; Claesson-Welsh L
    Cancer Res; 2004 Dec; 64(24):9012-7. PubMed ID: 15604266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenesis by cyclosporine.
    Iurlaro M; Vacca A; Minischetti M; Ribatti D; Pellegrino A; Sardanelli A; Giacchetta F; Dammacco F
    Exp Hematol; 1998 Dec; 26(13):1215-22. PubMed ID: 9845377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma cell-derived vascular endothelial growth factor induces endothelial tubulogenesis within fibrin gels by a metalloproteinase-mediated mechanism.
    Löffek S; Zigrino P; Steiger J; Kurschat P; Smola H; Mauch C
    Eur J Cell Biol; 2006 Nov; 85(11):1167-77. PubMed ID: 16949178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 389.